A vaccine delivery system promotes strong immune responses against SARS‐CoV‐2 variants
Journal of Medical Virology · 2023-02 · 95 (2)
DOI: 10.1002/jmv.28475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 17.01.2023. Verfasst von Zhiwei Lei und 18 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: COVID-19, Vaccines. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Global coronavirus disease 2019 (COVID‐19) pandemics highlight the need of developing vaccines with universal and durable protection against emerging SARS‐CoV‐2 variants. Here we developed an extended‐release vaccine delivery system (GP‐diABZI‐RBD), consisting the original SARS‐CoV‐2 WA1 strain receptor‐binding domain (RBD) as the antigen and diABZI stimulator of interferon genes (STING) agonist in conjunction with yeast β‐glucan particles (GP‐diABZI) as the platform. GP‐diABZI‐RBD could activate STING pathway and inhibit SARS‐CoV‐2 replication. Compared to diABZI‐RBD, intraperitoneal injection of GP‐diABZI‐RBD elicited robust cellular and humoral immune responses in mice. Using SARS‐CoV‐2 GFP/ΔN transcription and replication‐competent virus‐like particle system (trVLP), we demonstrated that GP‐diABZI‐RBD‐prototype vaccine exhibited the strongest and durable humoral immune responses and antiviral protection; whereas GP‐diABZI‐RBD‐Omicron displayed minimum neutralization responses against trVLP. By using pseudotype virus (PsVs) neutralization assay, we found that GP‐diABZI‐RBD‐Prototype, GP‐diABZI‐RBD‐Delta, and GP‐diABZI‐RBD‐Gamma immunized mice sera could efficiently neutralize Delta and Gamma PsVs, but had weak protection against Omicron PsVs. In contrast, GP‐diABZI‐RBD‐Omicron immunized mice sera displayed the strongest neutralization response to Omicron PsVs. Taken together, the results suggest that GP‐diABZI can serve as a promising vaccine delivery system for enhancing durable humoral and cellular immunity against broad SARS‐CoV‐2 variants. Our study provides important scientific basis for developing SARS‐CoV‐2 VOC‐specific vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.
- The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, China.
- Guangzhou Laboratory, Bioland, Guangzhou, China.
- Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
- Foshan Institute of Medical Microbiology, Foshan, China.
- State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.
ORCID-Profile: Zhiwei Lei, Zhen Luo, Qiwei Zhang
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Lei, Z., Zhu, L., Pan, P., Ruan, Z., Gu, Y., Xia, X., Wang, S., Ge, W., Yao, Y., Luo, F., Xiao, H., Guo, J., Ding, Q., Yin, Z., Li, Y., Luo, Z., Zhang, Q., Chen, X., & Wu, J. (2023). A vaccine delivery system promotes strong immune responses against SARS‐CoV‐2 variants. Journal of Medical Virology, 95(2). https://doi.org/10.1002/jmv.28475
Vancouver
Lei Z, Zhu L, Pan P, Ruan Z, Gu Y, Xia X, et al. A vaccine delivery system promotes strong immune responses against SARS‐CoV‐2 variants. Journal of Medical Virology. 2023;95(2). doi:10.1002/jmv.28475
BibTeX
@article{Lei2023,
author = {Lei, Zhiwei and Zhu, Leqing and Pan, Pan and Ruan, Zhihui and Gu, Yu and Xia, Xichun and Wang, Shengli and Ge, Weiwei and Yao, Yangrong and Luo, Fazeng and Xiao, Heng and Guo, Jun and Ding, Qiang and Yin, Zhinan and Li, Yongkui and Luo, Zhen and Zhang, Qiwei and Chen, Xin and Wu, Jianguo},
title = {A vaccine delivery system promotes strong immune responses against SARS‐CoV‐2 variants},
journal = {Journal of Medical Virology},
year = {2023},
volume = {95},
number = {2},
doi = {10.1002/jmv.28475}
}
EUVIMED